The role of global epigenetic changes in the aging process and age-related degenerative disorders is unknown. This proposal is based on the working hypothesis that specific cell types and tissues drive the aging process through global changes in the epigenome. To explore this hypothesis, we have conceived a novel system to address the methodological shortcomings that currently preclude cell-type-specific epigenetic analysis in complex tissues. The planned new approach, which we term Chromatin Isolation and Chromatin Immunoprecipitation (CI- ChIP), will involve transgenic expression of a tagged core histone in cells of interest using a cell type-specific promoter. The tagged histone would then be incorporated into the chromatin of the cells of interest, permitting the isolation of chromatin from specific cells in any animal model or complex tissue. We intend to use the nematode worm, Caenorhabditis elegans, to develop CI- ChIP. The genetic tractability and aging biology of the worm offers many advantages. Development of CI-ChIP would have immediate benefits for the study of gene expression and the epigenetics of aging in C. elegans. Furthermore, changes in gene expression during aging and under conditions that extend longevity could be measured at the tissue level for the first time. This will enable investigation of the molecular basis of differential rates of aging and the contribution of each of the major cell types in the worm. To explore the role of epigenetic changes in mammalian aging, CI-ChIP will be applied to transgenic mice expressing tagged histones targeted to tissues with pronounced age-related pathology, including the brain, heart, skeletal muscle, vasculature and pancreas. This would allow for global epigenetic analysis at cell type-specific resolution in any mouse model of disease, development or physiology. Finally, it is conceivable that CI-ChIP might lead to technology for predicting individuals at risk for age- related degenerative disorde

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
NIH Director’s Pioneer Award (NDPA) (DP1)
Project #
8DP1AG044161-03
Application #
8306995
Study Section
Special Emphasis Panel (ZGM1-NDPA-B (01))
Program Officer
Wise, Bradley C
Project Start
2010-09-30
Project End
2015-07-31
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
3
Fiscal Year
2012
Total Cost
$839,025
Indirect Cost
$344,025
Name
Harvard University
Department
Pathology
Type
Schools of Medicine
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115
Meyer, Katharina; Yankner, Bruce A (2017) Slowing Down Aging. Cell Metab 26:592-593
Aron, Liviu; Yankner, Bruce A (2016) Neurodegenerative disorders: Neural synchronization in Alzheimer's disease. Nature 540:207-208
Wolfe, Michael S; Yankner, Bruce A (2016) Sorting Out Presenilins in Alzheimer's Disease. Cell 166:13-5
Kang, Chanhee; Xu, Qikai; Martin, Timothy D et al. (2015) The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4. Science 349:aaa5612
Lu, Tao; Aron, Liviu; Zullo, Joseph et al. (2014) REST and stress resistance in ageing and Alzheimer's disease. Nature 507:448-54
Mosammaparast, Nima; Kim, Haeyoung; Laurent, Benoit et al. (2013) The histone demethylase LSD1/KDM1A promotes the DNA damage response. J Cell Biol 203:457-70
Gabuzda, Dana; Yankner, Bruce A (2013) Physiology: Inflammation links ageing to the brain. Nature 497:197-8
Lee, Peter C W; Dodart, Jean-Cosme; Aron, Liviu et al. (2013) Altered social behavior and neuronal development in mice lacking the Uba6-Use1 ubiquitin transfer system. Mol Cell 50:172-84
Sun, Fang; Park, Kevin K; Belin, Stephane et al. (2011) Sustained axon regeneration induced by co-deletion of PTEN and SOCS3. Nature 480:372-5
Lipinski, Marta M; Zheng, Bin; Lu, Tao et al. (2010) Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease. Proc Natl Acad Sci U S A 107:14164-9

Showing the most recent 10 out of 13 publications